Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF
18.06
+0.50 (2.85%)
Mar 10, 2026, 12:43 PM CET
Newron Pharmaceuticals Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 365 | 174 | 88 | 28 | 29 | 38 | |
| Market Cap Growth | 71.33% | 97.16% | 219.36% | -4.32% | -24.65% | -66.14% | |
| Enterprise Value | 373 | 209 | 118 | 44 | 34 | 23 | |
| Last Close Price | 17.56 | 8.95 | 4.95 | 1.55 | 1.62 | 2.15 | |
| PE Ratio | 15.79 | 11.72 | - | - | - | - | |
| Forward PE | - | 10.63 | - | 7.84 | - | - | |
| PS Ratio | 6.52 | 3.61 | 10.48 | 4.59 | 4.84 | 6.74 | |
| PB Ratio | 246.71 | 127.32 | -3.17 | -1.99 | 8.98 | 2.06 | |
| P/TBV Ratio | 246.87 | 127.32 | - | - | 8.98 | 2.06 | |
| EV/Sales Ratio | 6.67 | 4.34 | 13.95 | 7.26 | 5.77 | 4.13 | |
| EV/EBITDA Ratio | 11.30 | 8.52 | - | - | - | - | |
| EV/EBIT Ratio | 11.35 | 8.53 | - | - | - | - | |
| Debt / Equity Ratio | 33.23 | 34.62 | -1.62 | -3.25 | 13.87 | 1.53 | |
| Debt / EBITDA Ratio | 1.49 | 1.91 | - | - | - | - | |
| Net Debt / Equity Ratio | 5.92 | 27.88 | -1.20 | -1.63 | 2.73 | -0.28 | |
| Net Debt / EBITDA Ratio | 0.27 | 1.55 | -3.12 | -1.72 | -0.69 | 0.27 | |
| Net Debt / FCF Ratio | 0.38 | -2.31 | -3.53 | -2.06 | -0.74 | 0.31 | |
| Asset Turnover | 1.39 | 1.15 | 0.29 | 0.14 | 0.11 | 0.09 | |
| Quick Ratio | 1.40 | 2.42 | 0.62 | 5.50 | 10.58 | 5.50 | |
| Current Ratio | 1.51 | 2.60 | 0.68 | 5.65 | 10.79 | 5.50 | |
| Return on Equity (ROE) | - | - | - | - | -146.43% | -77.71% | |
| Return on Assets (ROA) | 50.97% | 36.44% | -23.05% | -18.96% | -15.19% | -20.26% | |
| Return on Invested Capital (ROIC) | 263.58% | 80.74% | -157.51% | -130.08% | -103.26% | -134.50% | |
| Return on Capital Employed (ROCE) | 165.20% | 64.80% | 380.00% | -41.40% | -26.40% | -40.80% | |
| Earnings Yield | 6.49% | 8.54% | -17.09% | -62.50% | -53.44% | -59.23% | |
| FCF Yield | 6.28% | -9.50% | -10.70% | -39.69% | -41.12% | -44.07% | |
| Buyback Yield / Dilution | -16.86% | -15.30% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.